title: Bivalirudin use during percutaneous coronary intervention in patients on chronic warfarin therapy.
authors.affiliation: Heart Center, Turku University Hospital and University of Turku, Finland. Electronic address: tuoski@utu.fi.
authors.forename: Tuomas
authors.initials: T
authors.lastname: Kiviniemi
authors.affiliation: Heart Center, Satakunta Central Hospital, Finland.
authors.forename: Pasi
authors.initials: P
authors.lastname: Karjalainen
authors.affiliation: Division of Cardiology, Department of Medicine, Oulu University Hospital, Finland.
authors.forename: Matti
authors.initials: M
authors.lastname: Niemelä
authors.affiliation: Division of Cardiology, Laboratory of Interventional Cardiology, Ospedale Maggiore, Bologna, Italy.
authors.forename: Andrea
authors.initials: A
authors.lastname: Rubboli
authors.affiliation: University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom.
authors.forename: Gregory Y H
authors.initials: GY
authors.lastname: Lip
authors.affiliation: Department of Medicine III, Martin Luther University Halle-Wittenberg, Germany.
authors.forename: Axel
authors.initials: A
authors.lastname: Schlitt
authors.affiliation: Heart Center, Turku University Hospital and University of Turku, Finland.
authors.forename: Wail
authors.initials: W
authors.lastname: Nammas
authors.affiliation: Heart Center, Turku University Hospital and University of Turku, Finland.
authors.forename: K E Juhani
authors.initials: KE
authors.lastname: Airaksinen
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage*; D000991:Antithrombins / Q000008:administration & dosage*; D005260:Female; D006629:Hirudins / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000008:administration & dosage*; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects / Q000379:methods*; D011994:Recombinant Proteins / Q000008:administration & dosage; D014859:Warfarin / Q000008:administration & dosage*
chemical_list: D000925:Anticoagulants; D000991:Antithrombins; D006629:Hirudins; D010446:Peptide Fragments; D011994:Recombinant Proteins; D014859:Warfarin; C074619:bivalirudin